|
LOC100190938 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.37420000045907E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.18640000001946E-06 |
| Normal-vs-Stage2 |
3.848800E-04 |
| Normal-vs-Stage3 |
6.55540000060739E-09 |
| Normal-vs-Stage4 |
1.0228999869355E-09 |
| Stage1-vs-Stage2 |
5.440200E-01 |
| Stage1-vs-Stage3 |
8.924100E-02 |
| Stage1-vs-Stage4 |
3.081800E-03 |
| Stage2-vs-Stage3 |
1.078570E-01 |
| Stage2-vs-Stage4 |
5.260100E-03 |
| Stage3-vs-Stage4 |
1.528360E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.8464999992155E-08 |
| Normal-vs-AfricanAmerican |
2.17259999999442E-05 |
| Normal-vs-Asian |
1.177900E-03 |
| Caucasian-vs-AfricanAmerican |
3.070600E-01 |
| Caucasian-vs-Asian |
8.168000E-02 |
| AfricanAmerican-vs-Asian |
5.260300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.70570000013193E-07 |
| Normal-vs-Female |
9.72770000107204E-08 |
| Male-vs-Female |
4.413400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.79259999999459E-06 |
| Normal-vs-Age(41-60Yrs) |
1.64010000025527E-07 |
| Normal-vs-Age(61-80Yrs) |
6.81859999573931E-08 |
| Normal-vs-Age(81-100Yrs) |
1.237770E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.263800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.137200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.497200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.362200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.784000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.506600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.08100000000222E-05 |
| Classical-VS-Follicular |
2.802400E-02 |
| Classical-VS-Other |
7.805600E-01 |
| Classical-VS-Normal |
3.07320000003664E-07 |
| Tall-VS-Follicular |
7.45230000043229E-07 |
| Tall-VS-Other |
2.542600E-01 |
| Tall-VS-Normal |
2.87350143679532E-11 |
| Follicular-VS-Other |
6.848800E-01 |
| Follicular-VS-Normal |
2.178600E-04 |
| Other-VS-Normal |
6.715800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.97040000041271E-07 |
| Normal-vs-N1 |
2.58669999975147E-07 |
| N0-vs-N1 |
4.831500E-02 |
|
|
